Vascular endothelial growth factor as a potential biomarker in systemic sclerosis: a systematic review and meta-analysis
IntroductionSystemic sclerosis (SSc), a chronic autoimmune condition, is characterized by microvascular dysfunction, ineffective angiogenesis, and fibrosis. The identification of robust biomarkers reflecting these processes may assist in clinical management and lead to the discovery of new therapies...
Saved in:
| Main Authors: | Angelo Zinellu, Arduino A. Mangoni |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2024-11-01
|
| Series: | Frontiers in Immunology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2024.1442913/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Endostatin as a biomarker of systemic sclerosis: insights from a systematic review and meta-analysis
by: Arduino A. Mangoni, et al.
Published: (2024-12-01) -
Endotheliopathy in systemic sclerosis: from endothelium-dependent vasodilation to the dysfunction of the vascular reserve, is the paradise lost?
by: Giulia Bandini, et al.
Published: (2025-05-01) -
CLINICAL ASSOCIATIONS OF VASCULAR ENDOTHELIAL GROWTH FACTOR AND ITS TYPE 2 RECEPTOR IN SYSTEMIC SCLEROSIS
by: R. T. Alekperov, et al.
Published: (2018-11-01) -
sCD40 and sCD40L as candidate biomarkers of rheumatic diseases: a systematic review and meta-analysis with meta-regression
by: Angelo Zinellu, et al.
Published: (2025-03-01) -
A systematic review and meta-analysis of pteridines in mild cognitive impairment and Alzheimer’s disease
by: Arduino A. Mangoni, et al.
Published: (2025-02-01)